Telemetry Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,000
Closed -$376K 201
2022
Q2
$376K Buy
+5,000
New +$376K 0.45% 72